Modified climbing fiber/Purkinje cell synaptic connectivity in the cerebellum of the neonatal phencyclidine model of schizophrenia.
Animals
Connective Tissue Growth Factor
/ genetics
Disease Models, Animal
Hallucinogens
/ administration & dosage
Mice
Neurons
/ drug effects
Phencyclidine
/ administration & dosage
Proto-Oncogene Proteins c-fos
/ metabolism
Purkinje Cells
/ drug effects
Receptors, Phencyclidine
/ agonists
Schizophrenia
/ chemically induced
Synapses
/ drug effects
cerebellum
development
phencyclidine
schizophrenia
synapse
Journal
Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876
Informations de publication
Date de publication:
24 05 2022
24 05 2022
Historique:
entrez:
19
5
2022
pubmed:
20
5
2022
medline:
24
5
2022
Statut:
ppublish
Résumé
Environmental perturbations during the first years of life are a major factor in psychiatric diseases. Phencyclidine (PCP), a drug of abuse, has psychomimetic effects, and neonatal subchronic administration of PCP in rodents leads to long-term behavioral changes relevant for schizophrenia. The cerebellum is increasingly recognized for its role in diverse cognitive functions. However, little is known about potential cerebellar changes in models of schizophrenia. Here, we analyzed the characteristics of the cerebellum in the neonatal subchronic PCP model. We found that, while the global cerebellar cytoarchitecture and Purkinje cell spontaneous spiking properties are unchanged, climbing fiber/Purkinje cell synaptic connectivity is increased in juvenile mice. Neonatal subchronic administration of PCP is accompanied by increased cFos expression, a marker of neuronal activity, and transient modification of the neuronal surfaceome in the cerebellum. The largest change observed is the overexpression of Ctgf, a gene previously suggested as a biomarker for schizophrenia. This neonatal increase in Ctgf can be reproduced by increasing neuronal activity in the cerebellum during the second postnatal week using chemogenetics. However, it does not lead to increased climbing fiber/Purkinje cell connectivity in juvenile mice, showing the complexity of PCP action. Overall, our study shows that administration of the drug of abuse PCP during the developmental period of intense cerebellar synaptogenesis and circuit remodeling has long-term and specific effects on Purkinje cell connectivity and warrants the search for this type of synaptic changes in psychiatric diseases.
Identifiants
pubmed: 35588456
doi: 10.1073/pnas.2122544119
pmc: PMC9173783
doi:
Substances chimiques
CCN2 protein, mouse
0
Hallucinogens
0
Proto-Oncogene Proteins c-fos
0
Receptors, Phencyclidine
0
Connective Tissue Growth Factor
139568-91-5
Phencyclidine
J1DOI7UV76
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2122544119Références
Cell. 2008 Nov 14;135(4):749-62
pubmed: 19013282
Biol Psychiatry. 2008 Jul 15;64(2):81-8
pubmed: 18395701
Cell. 2012 May 25;149(5):1152-63
pubmed: 22632977
Neuroscience. 2001;107(4):535-50
pubmed: 11720778
Neuroscience. 2002;113(1):1-10
pubmed: 12123679
Cerebellum. 2015 Feb;14(1):50-8
pubmed: 25503825
Psychopharmacology (Berl). 2013 Feb;225(3):579-94
pubmed: 22983144
J Natl Med Assoc. 1993 May;85(5):349-52
pubmed: 8496988
EMBO Rep. 2020 Aug 5;21(8):e48462
pubmed: 32558157
Nature. 2017 Apr 6;544(7648):96-100
pubmed: 28321129
Cortex. 2010 Jul-Aug;46(7):831-44
pubmed: 20152963
Psychopharmacology (Berl). 2005 Aug;181(1):134-44
pubmed: 15830220
Biol Pharm Bull. 2009 Sep;32(9):1576-83
pubmed: 19721235
Annu Rev Neurosci. 2018 Jul 8;41:233-253
pubmed: 29986160
Eur J Neurosci. 2003 Feb;17(3):545-54
pubmed: 12581172
Schizophr Bull. 2012 Sep;38(5):914-9
pubmed: 22390879
Nucleic Acids Res. 2010 Jul;38(13):4218-30
pubmed: 20308160
Eur Arch Psychiatry Clin Neurosci. 2016 Feb;266(1):35-41
pubmed: 25708455
Br J Pharmacol. 2011 Oct;164(4):1162-94
pubmed: 21449915
Neuron. 2013 Sep 18;79(6):1136-51
pubmed: 23993699
Elife. 2021 Sep 20;10:
pubmed: 34542409
Biomark Insights. 2010 May 12;5:39-47
pubmed: 20520744
PLoS Biol. 2011 Feb 08;9(2):e1001013
pubmed: 21346800
Neurosci Lett. 2019 Jan 1;688:62-75
pubmed: 29997061
Brain. 2003 Nov;126(Pt 11):2455-62
pubmed: 12876151
Neuropharmacology. 2016 Jan;100:90-7
pubmed: 25937215
J Neurosci. 2007 Oct 3;27(40):10797-809
pubmed: 17913913
Cell Rep. 2015 Feb 10;10(5):820-832
pubmed: 25660030
Bipolar Disord. 2006 Apr;8(2):133-43
pubmed: 16542183
Front Public Health. 2015 May 05;3:75
pubmed: 26000271
Nat Cell Biol. 2002 Aug;4(8):599-604
pubmed: 12134160
J Neurophysiol. 1996 May;75(5):1806-14
pubmed: 8734581
Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9985-90
pubmed: 8790444
Neuron. 2020 Apr 8;106(1):188-198.e5
pubmed: 32001108
Am J Psychiatry. 1980 Mar;137(3):359-61
pubmed: 7356066
Cerebellum. 2012 Jun;11(2):352-65
pubmed: 21373864
Arch Gen Psychiatry. 2000 Jan;57(1):65-73
pubmed: 10632234
Int Rev Neurobiol. 2013;113:1-34
pubmed: 24290381
Nat Neurosci. 2005 Nov;8(11):1534-41
pubmed: 16234806
Mol Psychiatry. 2012 Oct;17(10):996-1006
pubmed: 21931320
EMBO Mol Med. 2012 Oct;4(10):1043-56
pubmed: 23027611
Psychopharmacology (Berl). 2015 Nov;232(21-22):4085-97
pubmed: 25943167
Brain Res. 2011 Mar 10;1378:54-65
pubmed: 21241681
Biol Psychiatry. 2019 Jul 1;86(1):65-75
pubmed: 30850129
Nature. 2014 Feb 13;506(7487):185-90
pubmed: 24463508
Nature. 2014 Jul 24;511(7510):421-7
pubmed: 25056061
Neuron. 2015 Aug 19;87(4):781-96
pubmed: 26291161
Neuropharmacology. 2019 Nov 1;158:107745
pubmed: 31445017
Br J Pharmacol. 2015 Sep;172(17):4254-76
pubmed: 26075331
Neuron. 2009 Jul 16;63(1):27-39
pubmed: 19607790
J Comp Neurol. 1976 May 1;167(1):27-47
pubmed: 818132
Cereb Cortex. 2014 Sep;24(9):2522-32
pubmed: 23613110
J Neurosci. 1995 Mar;15(3 Pt 2):2097-108
pubmed: 7891155
Cerebellum. 2002 Jan-Mar;1(1):41-55
pubmed: 12879973
Mol Psychiatry. 2012 Dec;17(12):1228-38
pubmed: 22488257
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):2282-7
pubmed: 26858447
Neuron. 2015 Jan 21;85(2):316-29
pubmed: 25611509
Mol Psychiatry. 1999 Jan;4(1):39-45
pubmed: 10089007
Trends Neurosci. 1996 Nov;19(11):473-80
pubmed: 8931273
Schizophr Res. 2012 Aug;139(1-3):229-36
pubmed: 22682706
Neurotox Res. 2004;6(1):57-61
pubmed: 15184106
Neurochem Int. 2007 Jul-Sep;51(2-4):173-84
pubmed: 17669558
Arch Gen Psychiatry. 1997 Jul;54(7):660-9
pubmed: 9236550
Schizophr Bull. 2008 Nov;34(6):1047-53
pubmed: 18628273
Eur Psychiatry. 2007 Nov;22(8):499-504
pubmed: 17614262
Am J Psychiatry. 2019 Jul 1;176(7):512-520
pubmed: 30696271
Neuron. 2014 Aug 6;83(3):518-32
pubmed: 25102558
Brain. 2015 Feb;138(Pt 2):483-97
pubmed: 25524710
World Psychiatry. 2017 Oct;16(3):225-226
pubmed: 28941096
Nat Protoc. 2010 Sep;5(10):1678-96
pubmed: 20885380
Curr Psychiatry Rep. 2010 Aug;12(4):335-44
pubmed: 20556669
Proc Natl Acad Sci U S A. 2007 Sep 11;104(37):14843-8
pubmed: 17785415
Cell Rep. 2016 Apr 5;15(1):104-116
pubmed: 27052175
Cell Mol Life Sci. 2013 Dec;70(24):4667-80
pubmed: 23811844
Clin Neuropharmacol. 1998 Nov-Dec;21(6):320-32
pubmed: 9844787
Arch Gen Psychiatry. 2000 Apr;57(4):349-56
pubmed: 10768696
Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):12981-6
pubmed: 9371786
Arch Neurol. 1991 Nov;48(11):1178-87
pubmed: 1953406
Cell Rep. 2018 Jan 23;22(4):919-929
pubmed: 29386134
Science. 2019 Jan 18;363(6424):
pubmed: 30655412
Front Synaptic Neurosci. 2015 Feb 20;7:1
pubmed: 25750623
Proc Natl Acad Sci U S A. 1990 Apr;87(7):2662-5
pubmed: 1969639
Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 Sep;4(9):820-831
pubmed: 31495402
Schizophr Bull. 2008 Jan;34(1):155-72
pubmed: 17562694
Eur Neuropsychopharmacol. 2013 Nov;23(11):1414-22
pubmed: 23561394
Prog Neurobiol. 2004 Apr;72(5):295-339
pubmed: 15157725
J Neurocytol. 1993 Sep;22(9):689-95
pubmed: 7903688
Pharmacol Biochem Behav. 2008 Oct;90(4):569-77
pubmed: 18544461
J Comp Neurol. 1996 Oct 28;374(4):523-34
pubmed: 8910733
Behav Brain Res. 2008 Dec 12;194(2):230-5
pubmed: 18706451
Nature. 1994 Mar 24;368(6469):335-9
pubmed: 7907398
Nature. 2013 Jan 17;493(7432):327-37
pubmed: 23325215
Neuropharmacology. 2013 Sep;72:157-68
pubmed: 23643744
Science. 1992 Jun 26;256(5065):1823-5
pubmed: 1352066
Front Syst Neurosci. 2014 Nov 04;8:205
pubmed: 25408638
Nucleic Acids Res. 2017 Jan 4;45(D1):D362-D368
pubmed: 27924014
Biol Psychiatry. 1999 Jan 1;45(1):41-8
pubmed: 9894574
Elife. 2018 Sep 20;7:
pubmed: 30226467
Mol Psychiatry. 2019 Apr;24(4):549-561
pubmed: 29511299
J Neurochem. 2013 Feb;124(4):548-57
pubmed: 23083323
Nat Neurosci. 2013 Dec;16(12):1773-82
pubmed: 24162655
J Cell Biol. 2008 Jun 2;181(5):791-801
pubmed: 18504299
Mol Brain. 2019 Jun 20;12(1):57
pubmed: 31221179
FEBS Lett. 2006 Feb 20;580(5):1376-82
pubmed: 16457822
Science. 2011 Oct 21;334(6054):385-9
pubmed: 22021859
Schizophr Res. 2005 Mar 1;73(2-3):159-72
pubmed: 15653259
Matrix Biol. 2018 Aug;68-69:44-66
pubmed: 29574063
Proc Natl Acad Sci U S A. 2016 Aug 30;113(35):9898-903
pubmed: 27531957